Alnylam Pharmaceuticals
ALNY
#1041
Rank
$17.76 B
Marketcap
$148.50
Share price
0.34%
Change (1 day)
-10.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $17.76 Billion

As of January 2022 Alnylam Pharmaceuticals has a market cap of $17.76 Billion. This makes Alnylam Pharmaceuticals the world's 1041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2022

Year Market cap Change
2022$17.76 B-23.59%
2021$23.24 B53.94%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B

End of Day market cap according to different sources

On Jan 17th, 2022 the market cap of Alnylam Pharmaceuticals was reported to be:

$17.76 Billion
by Nasdaq
$17.76 Billion
by CompaniesMarketCap
$17.76 Billion
by Yahoo Finance
$17.76 Billion
by Iex Cloud
$17.76 Billion
by Reuters

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$202.56 B 1,040.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$130.37 B 634.06%๐Ÿ‡ซ๐Ÿ‡ท France
$66.16 B 272.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.19 B-65.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.03 B-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.08 B-82.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.17 B-42.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$6.04 B-65.98%๐Ÿ‡บ๐Ÿ‡ธ USA